Pacer Advisors
ICPT

Pacer Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Pacer Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,711
Closed -$86K – 1584
2021
Q1 		$86K Sell
3,711
-592
-14% -$16.5K ﹤0.01% 1310
2020
Q4 		$106K Buy
4,303
+2,906
+208% +$96.3K ﹤0.01% 1361
2020
Q3 		$58K Buy
+1,397
New +$64.2K ﹤0.01% 1298
2018
Q4 		– Sell
-3,301
Closed -$417K – 1100
2018
Q3 		$417K Buy
+3,301
New +$349K 0.02% 901
2018
Q1 		– Sell
-950
Closed -$55K – 1139
2017
Q4 		$55K Sell
950
-1,136
-54% -$71.6K ﹤0.01% 1003
2017
Q3 		$121K Buy
2,086
+225
+12% +$24.2K 0.01% 1049
2017
Q2 		$225K Hold
1,861
– – 0.02% 956
2017
Q1 		$210K Buy
1,861
+330
+22% +$38.5K 0.03% 895
2016
Q4 		$166K Buy
1,531
+147
+11% +$17.5K 0.02% 925
2016
Q3 		$228K Buy
1,384
+120
+9% +$18.9K 0.03% 753
2016
Q2 		$180K Buy
+1,264
New +$184K 0.03% 842
2016
Q1 		– Sell
-266
Closed -$40K – 863
2015
Q4 		$40K Buy
+266
New +$45K 0.01% 775

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Pacer Advisors's ICPT Position: Q2 2021 in Review

Pacer Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2021, closing a stake of 3,711 shares — an estimated $86K sold.

Pacer Advisors first reported a position in ICPT in Q4 2015 and held it in 12 quarters. The position peaked at $417K in Q3 2018. 129 funds tracked by Wall St. Rank hold ICPT as of Q2 2021.

  • Pacer Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 3,711 Intercept Pharmaceuticals, Inc. shares in Q2 2021, an estimated $86K.
  • Pacer Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 12 quarters.
  • Pacer Advisors's Intercept Pharmaceuticals, Inc. position peaked at $417K in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.